Clinical Trials List
2017-06-01 - 2021-01-06
Phase II
Terminated7
ICD-10C61
Malignant neoplasm of prostate
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Yu-Chieh Tsai Division of Hematology & Oncology
- JHE-CYUAN GUO Division of Hematology & Oncology
- CHUNG-HSIN CHEN Division of Urology
- YEN-HENG LIN Division of Radiology
- Yeong-Shiau Pu Division of Urology
- Ying-Chun Shen Division of Hematology & Oncology
- - - Division of Urology
- CHING-CHU LU Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
- 陳冠亨 Division of Urology
- Wei-Ching Lin Division of Radiology
- Po-Fan Hsieh Division of Urology
- Chi-Ping Huang Division of Urology
- Che-Hung Lin Division of Hematology & Oncology
- Po-Jen Hsiao 無
- Yi-Huei Chang Division of Urology
- Ching-Chan Lin Division of Urology
- 謝德鈞 Division of Nuclear Medicine
- Chao-Hsiang Chang Division of Urology
- Su-Peng Yeh Division of Hematology & Oncology
- Chi-Rei Yang Division of Urology
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Cheng-Kuang Yang Division of Urology
- 洪晟鈞 Division of Urology
- Jian-Ri Li Division of Urology
- Chia-Yen Lin Division of Urology
- 王樹吉 Division of Urology
- 熊小澐 Division of Radiology
- 裘坤元 Division of Urology
- 盧嘉文 Division of Urology
- Cheng-Che Chen Division of Urology
- Chuan-Shu Chen Division of Urology
- 蔡世傳 Division of Nuclear Medicine
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
The Actual Total Number of Participants Enrolled
0 Completed
Co-Principal Investigator
- Che-Yuan Hu Division of Hematology & Oncology
- Jiann-Hui Ou Division of Hematology & Oncology
- Nai-Jung Chiang Division of Hematology & Oncology
- 姜乃榕 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Completed
Audit
None
Co-Principal Investigator
Audit
None
Co-Principal Investigator
- 盧凱傑 Division of Hematology & Oncology
- Rita cheng Division of Hematology & Oncology
- Po-Jung Su Division of Hematology & Oncology
- Yung-Chang Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
1 Completed
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
9 participants
-
Global
289 participants
